NEDC Fact Sheet - Binge Eating Disorder

About this resource

AuthorNEDC
Year2011

See also

Review of the prevalence and incidence of eating disorders

OBJECTIVE: To review the literature on the incidence and prevalence of eating disorders.

Read more

Placebo-controlled trial of sertraline in the treatment of binge eating disorder

OBJECTIVE: The authors' goal was to assess the efficacy of sertraline in the treatment of binge eating disorder.

Read more

43. Overview of Data Supporting the Efficacy of Lisdexamfetamine Dimesylate in the Treatment of Binge Eating Disorder

The stimulant pro-drug lisdexamfetamine dimesylate (LDX) is the only drug that has regulatory approval for the treatment of binge eating disorder (BED).

Read more

Recurrent binge eating with and without the undue influence of weight or shape on self-evaluation": Implications for the diagnosis of binge eating disorder"

Levels of eating disorder psychopathology, impairment in psycho-social functioning and use of health services were compared among probable cases of binge eating disorder (BED) with and without extreme weight or shape concerns ("undue influence of weight or shape on self-evaluation") recruited from a large community sample of women.

Read more

Help us improve!

Give us feedback!

We will continue throughout 2019 to update and improve the NEDC website and welcome any feedback you may have on the site.

Provide feedback